Antibody response to phenolic glycolipid I and Mycobacterium w antigens and its relation to bacterial load in M. leprae-infected mice and leprosy patients. 1989

K D Moudgil, and S K Gupta, and P R Naraynan, and L M Srivastava, and R S Mishra, and G P Talwar
Department of Biochemistry, All India Institute of Medical Sciences, New Delhi.

Twenty-six inbred BALB/cBy mice were infected with live Mycobacterium leprae by injecting 6 x 10(3) bacilli in the hind footpad. Bleeds were collected at monthly intervals. After 6 months, acid-fast bacilli (AFB) were harvested monthly from the footpad of mice. The sera were analysed in enzyme immunoassay for antibodies against phenolic glycolipid I (PGL-I) of M. leprae and antigens of Mycobacterium w (M. w); 21 out of 26 (80.7%) mice demonstrated the presence of antibodies against PGL-I and M. w . Anti-M. w antibodies appeared slightly earlier than did anti-PGL-I antibodies. The titre of anti-M. w antibodies was higher than that of anti-PGL-I antibodies. The mice giving a positive antibody response had more than 7 x 10(5) AFB/footpad. The coefficient of correlation (r) between the number of AFB and antibody titres at the time of harvest was 0.566 for PGL-I and 0.628 for M. w. The value of r for bacterial index and antibody titres in 188 leprosy patients was 0.510 for PGL-I and 0.418 for M. w; these values were statistically significant (P < 0.001). The decrease in bacterial index and antibody titres in treated lepromatous leprosy patients correlated with increase in the duration of chemotherapy. The measurement of anti-PGL-I antibodies of IgM class may serve as an adjunct to skin biopsy and skin-slit smear for serial monitoring of the bacterial load in the course of chemotherapy in leprosy control programmes.

UI MeSH Term Description Entries
D007075 Immunoglobulin M A class of immunoglobulin bearing mu chains (IMMUNOGLOBULIN MU-CHAINS). IgM can fix COMPLEMENT. The name comes from its high molecular weight and originally was called a macroglobulin. Gamma Globulin, 19S,IgM,IgM Antibody,IgM1,IgM2,19S Gamma Globulin,Antibody, IgM
D007918 Leprosy A chronic granulomatous infection caused by MYCOBACTERIUM LEPRAE. The granulomatous lesions are manifested in the skin, the mucous membranes, and the peripheral nerves. Two polar or principal types are lepromatous and tuberculoid. Hansen's Disease,Hansen Disease
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D009161 Mycobacterium A genus of gram-positive, aerobic bacteria. Most species are free-living in soil and water, but the major habitat for some is the diseased tissue of warm-blooded hosts. Mycobacteria
D009166 Mycobacterium leprae A species of gram-positive, aerobic bacteria that causes LEPROSY in man. Its organisms are generally arranged in clumps, rounded masses, or in groups of bacilli side by side.
D003429 Cross Reactions Serological reactions in which an antiserum against one antigen reacts with a non-identical but closely related antigen. Cross Reaction,Reaction, Cross,Reactions, Cross
D006017 Glycolipids Any compound containing one or more monosaccharide residues bound by a glycosidic linkage to a hydrophobic moiety such as an acylglycerol (see GLYCERIDES), a sphingoid, a ceramide (CERAMIDES) (N-acylsphingoid) or a prenyl phosphate. (From IUPAC's webpage) Glycolipid
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000907 Antibodies, Bacterial Immunoglobulins produced in a response to BACTERIAL ANTIGENS. Bacterial Antibodies

Related Publications

K D Moudgil, and S K Gupta, and P R Naraynan, and L M Srivastava, and R S Mishra, and G P Talwar
May 1985, Infection and immunity,
K D Moudgil, and S K Gupta, and P R Naraynan, and L M Srivastava, and R S Mishra, and G P Talwar
December 1986, Journal of clinical microbiology,
K D Moudgil, and S K Gupta, and P R Naraynan, and L M Srivastava, and R S Mishra, and G P Talwar
August 2017, Cell,
K D Moudgil, and S K Gupta, and P R Naraynan, and L M Srivastava, and R S Mishra, and G P Talwar
December 1987, Australian and New Zealand journal of medicine,
K D Moudgil, and S K Gupta, and P R Naraynan, and L M Srivastava, and R S Mishra, and G P Talwar
July 1990, The Journal of infectious diseases,
K D Moudgil, and S K Gupta, and P R Naraynan, and L M Srivastava, and R S Mishra, and G P Talwar
December 1999, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease,
K D Moudgil, and S K Gupta, and P R Naraynan, and L M Srivastava, and R S Mishra, and G P Talwar
December 1988, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association,
K D Moudgil, and S K Gupta, and P R Naraynan, and L M Srivastava, and R S Mishra, and G P Talwar
March 1986, The Journal of infectious diseases,
K D Moudgil, and S K Gupta, and P R Naraynan, and L M Srivastava, and R S Mishra, and G P Talwar
January 1984, Acta leprologica,
K D Moudgil, and S K Gupta, and P R Naraynan, and L M Srivastava, and R S Mishra, and G P Talwar
October 1990, Journal of general microbiology,
Copied contents to your clipboard!